Compounds > 1-methyl-3-isobutylxanthine

1-methyl-3-isobutylxanthine and losartan potassium

1-methyl-3-isobutylxanthine has been researched along with losartan potassium in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burns, ER; Sherwood, JB; Shouval, D1
Kawakita, M; Sakaguchi, M; Sawada, T; Takatsuki, K; Tsuda, H1
George, WJ; White, LE1
Fandrey, J; Frede, S; Huwiler, A; Jelkmann, W; Pfeilschifter, J1
Bulaeva, SV; Miloradov, MJ; Muravyov, AV; Tikhomirova, IA; Uzikova, EV; Zamishlayev, AV1
Chen, ST; Chen, XY; Lai, Q; Liu, CC; Liu, GX; Zhu, AZ; Zhu, JC1

Trials

1 trial(s) available for 1-methyl-3-isobutylxanthine and losartan potassium

ArticleYear
Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment.
    Clinical hemorheology and microcirculation, 2011, Volume: 49, Issue:1-4

    Topics: 1-Methyl-3-isobutylxanthine; Adult; Aged; Anemia; Blood Transfusion; Erythrocytes; Erythropoietin; Female; Hemorheology; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Organoplatinum Compounds; Pentoxifylline; Peripheral Arterial Disease; Phosphodiesterase Inhibitors; Prospective Studies; Recombinant Proteins; Rolipram; Vinca Alkaloids; Young Adult

2011

Other Studies

5 other study(ies) available for 1-methyl-3-isobutylxanthine and losartan potassium

ArticleYear
Stimulation by cAMP of erythropoietin secretion by an established human renal carcinoma cell line.
    Blood, 1987, Volume: 69, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Carcinoma, Renal Cell; Cell Line; Cyclic AMP; Erythropoietin; Humans; Secretory Rate; Time Factors

1987
Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. I. Involvement of adenosine 3',5'-cyclic monophosphate not as a second messenger but as a regulator of cell growth.
    Experimental hematology, 1989, Volume: 17, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Cell Division; Cell Line, Transformed; Cholera Toxin; Cyclic AMP; Erythropoietin; Growth Substances; Interleukin-3; Intracellular Fluid; Kinetics; Mice; Second Messenger Systems

1989
Increased concentrations of cyclic GMP in fetal liver cells stimulated by erythropoietin.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1981, Volume: 166, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cells, Cultured; Cyclic AMP; Cyclic GMP; DNA; Erythropoietin; Heme; Liver; Rats

1981
Distinct signaling pathways mediate phorbol-ester-induced and cytokine-induced inhibition of erythropoietin gene expression.
    European journal of biochemistry, 1994, Dec-01, Volume: 226, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Bucladesine; Carcinoma, Hepatocellular; Cell Hypoxia; Cyclic AMP; Cytokines; Erythropoietin; Gene Expression; Humans; Interleukin-1; Isoenzymes; Kinetics; Liver Neoplasms; Protein Kinase C; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1994
Inhibition of adipogenic differentiation of bone marrow mesenchymal stem cells by erythropoietin via activating ERK and P38 MAPK.
    Genetics and molecular research : GMR, 2015, Jun-26, Volume: 14, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; Adipocytes; Adiponectin; Animals; Bone Marrow Cells; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Dexamethasone; Enzyme Activation; Erythropoietin; Fatty Acid-Binding Proteins; Gene Expression Regulation; Insulin; Male; Mesenchymal Stem Cells; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Primary Cell Culture; RNA, Messenger; Signal Transduction

2015